These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7536351)
1. [Levels of prostate-specific antigen, acid phosphatase, alkaline phosphatase and pain in the prediction of bone metastases in patients with newly diagnosed prostatic carcinoma]. Kliment J; Eliás B; Svihra J Rozhl Chir; 1994 Sep; 73(6):300-2. PubMed ID: 7536351 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer. Lorente JA; Morote J; Raventos C; Encabo G; Valenzuela H J Urol; 1996 Apr; 155(4):1348-51. PubMed ID: 8632571 [TBL] [Abstract][Full Text] [Related]
3. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen. Morote J; Lorente JA; Encabo G Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009 [TBL] [Abstract][Full Text] [Related]
4. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459 [TBL] [Abstract][Full Text] [Related]
5. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase. Wymenga LF; Boomsma JH; Groenier K; Piers DA; Mensink HJ BJU Int; 2001 Aug; 88(3):226-30. PubMed ID: 11488734 [TBL] [Abstract][Full Text] [Related]
6. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan. Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464 [TBL] [Abstract][Full Text] [Related]
7. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer]. Wang ZL; Wang XF Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of bone metastasis in men with prostate cancer by measurement of serum ICTP in combination with alkali phosphatase and prostate-specific antigen. Kataoka A; Yuasa T; Kageyama S; Tsuchiya N; Habuchi T; Iwaki H; Narita M; Okada Y; Yoshiki T Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):480-4. PubMed ID: 16909972 [TBL] [Abstract][Full Text] [Related]
9. Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase. Xie W; Nakabayashi M; Regan MM; Oh WK Cancer; 2007 Dec; 110(12):2709-15. PubMed ID: 17960608 [TBL] [Abstract][Full Text] [Related]
10. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase. Wolff JM; Ittel TH; Borchers H; Boekels O; Jakse G Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213 [TBL] [Abstract][Full Text] [Related]
11. [Prostate-specific antigen, acid phosphatases and rectal exploration in the diagnosis of prostatic cancer]. Andersen BR; Knorr UB; Brasso K; Iversen P Ugeskr Laeger; 1997 Apr; 159(17):2538-42. PubMed ID: 9182382 [TBL] [Abstract][Full Text] [Related]
12. [Is skeletal alkaline phosphatase a valid staging marker in detection of osteoblastic skeletal metastases of prostate carcinoma?]. Wirtz DC; Wolff JM; Ittel TH; Jakse G; Niethard FU Z Orthop Ihre Grenzgeb; 1998; 136(3):255-9. PubMed ID: 9736988 [TBL] [Abstract][Full Text] [Related]
13. A reappraisal of serial isotope bone scans in prostate cancer. O'Donoghue JM; Rogers E; Grimes H; McCarthy P; Corcoran M; Bredin H; Given HF Br J Radiol; 1993 Aug; 66(788):672-6. PubMed ID: 7536607 [TBL] [Abstract][Full Text] [Related]
14. [Usefulness of bone-specific alkaline phosphatase for bone metastases detection in prostate cancer]. Rasch-Isla Muñoz A; Cataño Cataño JG Arch Esp Urol; 2004 Sep; 57(7):693-8. PubMed ID: 15536950 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of alpha1-antichymotrypsin-PSA complex for predicting bone metastases of prostate cancer. Kikuchi E; Nakashima J; Ishibashi M; Ohigashi T; Oya M; Nakagawa K; Miyajima A; Murai M Urology; 2006 Aug; 68(2):371-5. PubMed ID: 16904455 [TBL] [Abstract][Full Text] [Related]
16. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival]. Lobo G; Ladrón de Guevara D; Salgado G; Donoso G; Bagus F Rev Med Chil; 1999 Feb; 127(2):181-8. PubMed ID: 10436698 [TBL] [Abstract][Full Text] [Related]
17. The value of pretreatment clinical and biochemical parameters in staging and prognostic stratification of patients with newly diagnosed prostate carcinoma. Stokkel MP; Zwinderman AH; Zwartendijk J; Pauwels EK; Van Eck-Smit BL Int J Biol Markers; 1998; 13(2):70-6. PubMed ID: 9803354 [TBL] [Abstract][Full Text] [Related]
18. Metastatic workup of patients with prostate cancer employing skeletal alkaline phosphatase. Wolff JM; Ittel TH; Boeckmann W; Habib FK; Jakse G Anticancer Res; 1997; 17(4B):2995-7. PubMed ID: 9329584 [TBL] [Abstract][Full Text] [Related]
19. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer. Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119 [TBL] [Abstract][Full Text] [Related]
20. [Is it possible to do without bone gammagraphy in the staging of prostatic cancer?]. Ruiz de la Roja JC; Llorente Abarca C; Romero Cagigal I; Páez Borda A; Fernández González I; Martín Osés E; Berenguer Sánchez A Actas Urol Esp; 1995 Feb; 19(2):123-7. PubMed ID: 7539572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]